Medlab Clinical Limited (ASX: MDC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Medlab Clinical Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Medlab Clinical Limited (ASX: MDC)
    Latest News

    a woman
    ⏸️ Investing

    Here are 2017's best performing ASX pot stocks

    Australia’s pot stocks have been a hot topic this year. And some have proved very lucrative for shareholders.

    Read more »

    a woman
    ⏸️ Investing

    Here's Medlab Clinical Ltd's 'world first' plan to test cannabis on Sydney patients

    The Medlab Clinical Ltd (ASX:MDC) plans to test cannabis at Royal North Shore Hospital. And investors seem to think that’s…

    Read more »

    MDC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Matthew John Hudson Non-Executive Director Mar 2023
    Mr Hudson has experience raising capital for projects based in Africa, Latin America, and Asia. He is a former Credit Suisse and Arthur Andersen advisor, who is now the Co-Founder and Managing Director of Hudson Koch Energy, which operates 43 oil and gas wells across Kansas and Oklahoma. He is also the Founder and Managing Director of United Minerals which operated the historic Potosi Mine in Chihuahua, Mexico.
    Mr Sean Michael Hall Chief Executive Officer Apr 2014
    Mr Hall has over 20 years of experience in the Australian Healthcare and food industries and early phase drug discovery in Australia and Asia. Sean is best known for building Australia's practitioner brand, BioCeuticals. Dr Hall is a member of Medicines Australia, American Federation for Medical Research, American Academy of Anti-Ageing Medicine, Ausbiotech, a member of the Scientific Advisory Board for BITs Life Science China and a Board Member of the International Probiotics Association.
    Mr Tim Walker Non-Executive Director Mar 2024
    Mr Walker is a corporate finance professional with experience in originating, managing, and leading resource-focused transaction. Specialising in M&A transactions across the Canadian and Australian markets, IPOs, and equity and debt financing solutions. Tim's past directorships with exploration companies have provided him with experience across commodity groups, including lithium exploration, rare earth and niobium hosted carbonatite deposits, whilst also having experience transacting on iron ore and base metal projects.
    Mr Edmond Tan Non-Executive Director Mar 2024
    Mr Tan is a financial services professional with over 10 years' experience in roles which include Private Wealth Management, Family Office, and Structured Finance. In addition, he was involved in the establishment of a mid-market private equity joint venture fund with a focus on foreign investment into Australia. Currently, Mr Tan is a Director of Regenerate Pty Ltd a rare earth magnet recycling technology based in Houston, Texas. He is also the Australian Representative for Obsidian Global Partners LLC, a structured financier for ASX listed companies.
    Mr Kerem Kaya Chief Financial OfficerCompany Secretary May 2021
    -
    Kerem Kaya Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Sean Michael Hall 389,041 17.04%
    Farjoy Pty Ltd 205,663 9.01%
    HSBC Custody Nominees (Australia) Limited 88,229 3.86%
    UBS Nominees Pty Ltd 85,316 3.74%
    Fit Investments Pty Ltd Hallab Investment A/C 75,563 3.31%
    Realm Group Pty Limited 54,705 2.40%
    Citicorp Nominees Pty Limited 49,798 2.18%
    Mr Drew Anthony Townsend Townsend Family A/C 37,038 1.62%
    Richard Albarran Albarran Family No 2 A/C 37,038 1.62%
    United Trolley Collections P/L 32,970 1.44%
    BNP Paribas Nominees Pty Ltd Ib Au Noms Retailclient 30,272 1.33%
    Mr Michael Jack Hall & Mrs Elizabeth Ann Jones Hall Jones Super Fund A/C 29,820 1.31%
    Netwealth Investments Limited Wrap Services A/C 20,186 0.88%
    Villamagna Inc 20,000 0.88%
    BNP Paribas Noms Pty Ltd 17,164 0.75%
    Daniel P Moses (Nominees) Pty Limited Daniel Moses Family A/C 16,667 0.73%
    Acron Holdings Pty Limited Acron Super Fund A/C 16,181 0.71%
    Kenney Family Investments Pty Ltd Kenney Family Account 15,295 0.67%
    Assumo (Nominees) Pty Ltd Assumo S/Fund A/C 13,334 0.58%
    D J Fairfull Pty Ltd Fairfull Super Fund A/C 12,651 0.55%

    Profile

    since

    Note